155 related articles for article (PubMed ID: 32403104)
1. Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice.
Cives M; Pellè E; Rinzivillo M; Prosperi D; Tucci M; Silvestris F; Panzuto F
Neuroendocrinology; 2021; 111(3):207-216. PubMed ID: 32403104
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition.
Cives M; Rizzo F; Simone V; Bisceglia F; Stucci S; Seeber A; Spizzo G; Montrone T; Resta L; Silvestris F
Neuroendocrinology; 2016; 103(3-4):321-34. PubMed ID: 26227818
[TBL] [Abstract][Full Text] [Related]
3. Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
Lim KHJ; Raja H; D'Arienzo P; Barriuso J; McNamara MG; Hubner RA; Mansoor W; Valle JW; Lamarca A
Neuroendocrinology; 2020; 110(7-8):688-696. PubMed ID: 31639796
[TBL] [Abstract][Full Text] [Related]
4. Bone metastases in neuroendocrine tumors.
Zamborsky R; Svec A; Kokavec M; Galbavy S
Bratisl Lek Listy; 2017; 118(9):529-534. PubMed ID: 29061059
[TBL] [Abstract][Full Text] [Related]
5. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
6. Bone metastases in well-to-moderately differentiated neuroendocrine tumors: a single institutional review from the Ohio State University Medical Center.
Kavecansky J; Wei L; Caronia L; Ramirez MT; Bloomston M; Shah MH
Pancreas; 2015 Mar; 44(2):198-203. PubMed ID: 25411805
[TBL] [Abstract][Full Text] [Related]
7. Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance.
Scharf M; Petry V; Daniel H; Rinke A; Gress TM
Neuroendocrinology; 2018; 106(1):30-37. PubMed ID: 28152537
[TBL] [Abstract][Full Text] [Related]
8. Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis.
Garcia-Torralba E; Spada F; Lim KHJ; Jacobs T; Barriuso J; Mansoor W; McNamara MG; Hubner RA; Manoharan P; Fazio N; Valle JW; Lamarca A
Cancer Treat Rev; 2021 Mar; 94():102168. PubMed ID: 33730627
[TBL] [Abstract][Full Text] [Related]
9. Bone metastases and skeletal-related events from neuroendocrine tumors.
Van Loon K; Zhang L; Keiser J; Carrasco C; Glass K; Ramirez MT; Bobiak S; Nakakura EK; Venook AP; Shah MH; Bergsland EK
Endocr Connect; 2015 Mar; 4(1):9-17. PubMed ID: 25430999
[TBL] [Abstract][Full Text] [Related]
10. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of metastases in neuroendocrine tumors.
Riihimäki M; Hemminki A; Sundquist K; Sundquist J; Hemminki K
Int J Cancer; 2016 Dec; 139(12):2679-2686. PubMed ID: 27553864
[TBL] [Abstract][Full Text] [Related]
12. The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers.
Haidar M; Shamseddine A; Panagiotidis E; Jreige M; Mukherji D; Assi R; Abousaid R; Ibrahim T; Haddad MM; Vinjamuri S
Nucl Med Commun; 2017 Feb; 38(2):170-177. PubMed ID: 27922538
[TBL] [Abstract][Full Text] [Related]
13. Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
Cives M; Quaresmini D; Rizzo FM; Felici C; D'Oronzo S; Simone V; Silvestris F
Oncotarget; 2017 Apr; 8(14):22534-22549. PubMed ID: 28186979
[TBL] [Abstract][Full Text] [Related]
14. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.
Eltawil KM; Gustafsson BI; Kidd M; Modlin IM
J Clin Gastroenterol; 2010; 44(10):687-95. PubMed ID: 20375728
[TBL] [Abstract][Full Text] [Related]
16. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Rizzo FM; Vesely C; Childs A; Marafioti T; Khan MS; Mandair D; Cives M; Ensell L; Lowe H; Akarca AU; Luong T; Caplin M; Toumpanakis C; Krell D; Thirlwell C; Silvestris F; Hartley JA; Meyer T
Br J Cancer; 2019 Feb; 120(3):294-300. PubMed ID: 30636773
[TBL] [Abstract][Full Text] [Related]
18. Gastroenteropancreatic Neuroendocrine Tumors.
Cives M; Strosberg JR
CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging and Therapy for Neuroendocrine Tumors.
Desai H; Borges-Neto S; Wong TZ
Curr Treat Options Oncol; 2019 Aug; 20(10):78. PubMed ID: 31468190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]